Víctor Amado

405 total citations
12 papers, 274 citations indexed

About

Víctor Amado is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Víctor Amado has authored 12 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Hepatology. Recurrent topics in Víctor Amado's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver physiology and pathology (3 papers) and RNA Research and Splicing (3 papers). Víctor Amado is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver physiology and pathology (3 papers) and RNA Research and Splicing (3 papers). Víctor Amado collaborates with scholars based in Spain, United States and United Kingdom. Víctor Amado's co-authors include Manuel Rodríguez‐Perálvarez, Manuel de la Mata, Gustavo Ferrín, Rubén Ciria, Marina Sánchez‐Frías, Javier Briceño, Manuel de la Mata, Juan L López-Cánovas, Manuel D. Gahete and Mercedes del Río-Moreno and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Víctor Amado

11 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Víctor Amado Spain 9 141 82 72 51 48 12 274
Kyung Joo Cho South Korea 9 172 1.2× 109 1.3× 60 0.8× 70 1.4× 77 1.6× 15 317
Letizia Satriano Denmark 5 132 0.9× 34 0.4× 104 1.4× 43 0.8× 55 1.1× 6 250
Hesham M. Hassabo United States 8 174 1.2× 191 2.3× 113 1.6× 67 1.3× 159 3.3× 17 401
Fudong Lv China 9 159 1.1× 84 1.0× 102 1.4× 88 1.7× 92 1.9× 13 312
Atsutaka Masuda Japan 9 142 1.0× 61 0.7× 92 1.3× 32 0.6× 85 1.8× 19 279
Timothy A. Dinh United States 9 205 1.5× 81 1.0× 133 1.8× 27 0.5× 46 1.0× 15 307
Elina Zorde‐Khvalevsky Israel 8 156 1.1× 51 0.6× 146 2.0× 78 1.5× 33 0.7× 9 309
Kenji Fukumoto Japan 8 106 0.8× 42 0.5× 44 0.6× 72 1.4× 60 1.3× 18 288

Countries citing papers authored by Víctor Amado

Since Specialization
Citations

This map shows the geographic impact of Víctor Amado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Víctor Amado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Víctor Amado more than expected).

Fields of papers citing papers by Víctor Amado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Víctor Amado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Víctor Amado. The network helps show where Víctor Amado may publish in the future.

Co-authorship network of co-authors of Víctor Amado

This figure shows the co-authorship network connecting the top 25 collaborators of Víctor Amado. A scholar is included among the top collaborators of Víctor Amado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Víctor Amado. Víctor Amado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
López-Cánovas, Juan L, Mercedes del Río-Moreno, Antonio C. Fuentes-Fayos, et al.. (2023). PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing. Experimental & Molecular Medicine. 55(1). 132–142. 15 indexed citations
3.
López-Cánovas, Juan L, Mercedes del Río-Moreno, Emilia Alors‐Pérez, et al.. (2022). Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing. Clinical and Translational Medicine. 12(11). e1102–e1102. 14 indexed citations
4.
Zamora, Javier, Víctor Amado, Marina Sánchez‐Frías, et al.. (2021). Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal. International Journal of Molecular Sciences. 22(23). 13073–13073. 23 indexed citations
5.
Amado, Víctor, Javier Zamora, Marina Sánchez‐Frías, et al.. (2021). Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation. Cancers. 13(10). 2476–2476. 22 indexed citations
6.
Ferrín, Gustavo, et al.. (2020). Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 21(4). 1266–1266. 94 indexed citations
7.
López-Cánovas, Juan L, Mercedes del Río-Moreno, Juan M. Jiménez‐Vacas, et al.. (2020). Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma. Cancer Letters. 496. 72–83. 53 indexed citations
8.
Ferrín, Gustavo, Manuel Rodríguez‐Perálvarez, Marina Sánchez‐Frías, et al.. (2019). mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence. International Journal of Molecular Sciences. 20(2). 336–336. 13 indexed citations
9.
Rodríguez‐Perálvarez, Manuel, Beatriz Gros, Douglas Thorburn, et al.. (2019). Area Under Trough Concentrations of Tacrolimus as a Predictor of Progressive Renal Impairment After Liver Transplantation. Transplantation. 103(12). 2539–2548. 16 indexed citations
10.
Amado, Víctor, Manuel Rodríguez‐Perálvarez, Gustavo Ferrín, & Manuel de la Mata. (2018). Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria. SHILAP Revista de lepidopterología. Volume 6. 1–10. 22 indexed citations
11.
12.
Kittaneh, Muaiad, Alberto J. Montero, Víctor Amado, et al.. (2011). Phase I trial of weekly and every 3 weeks ixabepilone (Ix) and sunitinib (S) in advanced solid tumors (STs).. Journal of Clinical Oncology. 29(15_suppl). 3081–3081. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyung Joo Cho Breakdown of academic impact, for papers by Letizia Satriano Breakdown of academic impact, for papers by Hesham M. Hassabo Breakdown of academic impact, for papers by Fudong Lv Breakdown of academic impact, for papers by Atsutaka Masuda Breakdown of academic impact, for papers by Timothy A. Dinh Breakdown of academic impact, for papers by Elina Zorde‐Khvalevsky Breakdown of academic impact, for papers by Kenji Fukumoto
Rankless by CCL
2026